Market Research Logo

Gilead Sciences, Inc. - Product Pipeline Review - 2016

Gilead Sciences, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Gilead Sciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Gilead Sciences, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Gilead Sciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Gilead Sciences, Inc.
The report provides overview of Gilead Sciences, Inc. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Gilead Sciences, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Gilead Sciences, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Gilead Sciences, Inc.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Gilead Sciences, Inc.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Gilead Sciences, Inc.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Gilead Sciences, Inc. Snapshot
Gilead Sciences, Inc. Overview
Key Information
Key Facts
Gilead Sciences, Inc. - Research and Development Overview
Key Therapeutic Areas
Gilead Sciences, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Pipeline Products - Out-Licensed Products
Gilead Sciences, Inc. - Pipeline Products Glance
Gilead Sciences, Inc. - Late Stage Pipeline Products
Gilead Sciences, Inc. - Clinical Stage Pipeline Products
Gilead Sciences, Inc. - Early Stage Pipeline Products
Gilead Sciences, Inc. - Drug Profiles
(emtricitabine + rilpivirine hydrochloride + tenofovir alafenamide)
(emtricitabine + tenofovir alafenamide fumarate)
(sofosbuvir + velpatasvir)
tenofovir alafenamide
(cobicistat + elvitegravir + emtricitabine + tenofovir alafenamide fumarate)
(emtricitabine + GS-9883 + tenofovir alafenamide)
(GS-9857 + sofosbuvir + velpatasvir)
ambrisentan
eleclazine
GS-5745
idelalisib
momelotinib dihydrochloride
acalisib
entospletinib
GS-4774
presatovir
ranolazine ER
regadenoson
selonsertib
selonsertib + simtuzumab
simtuzumab
vesatolimod
GS-5829
GS-5734
GS-9674
GS-9876
ONO-4059
GS-459679
GS-548202
GS-5759
GS-607601
GS-8374
GS-967
GS-986
Monoclonal Antibodies 1 for Oncology
Monoclonal Antibody for HIV / AIDS
Monoclonal Antibody to Target HIV-Envelope and CD3 for HIV
Px-103
Small Molecule to Inhibit Histone Deacetylation for Oncology
Small Molecule to Inhibit Histone Methyltransferase for Oncology
GS-563253
GS-599220
Small Molecule for RSV
Small Molecule to Inhibit NS4B Protein for HCV
Small Molecules for Hepatitis C Infection
Small Molecules to Inhibit NS3 Protease for Hepatitis C
Small Molecules to Inhibit NS5B for Hepatitis C
Gilead Sciences, Inc. - Pipeline Analysis
Gilead Sciences, Inc. - Pipeline Products by Target
Gilead Sciences, Inc. - Pipeline Products by Route of Administration
Gilead Sciences, Inc. - Pipeline Products by Molecule Type
Gilead Sciences, Inc. - Pipeline Products by Mechanism of Action
Gilead Sciences, Inc. - Recent Pipeline Updates
Gilead Sciences, Inc. - Dormant Projects
Gilead Sciences, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Gilead Sciences, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Gilead Sciences, Inc., Key Information
Gilead Sciences, Inc., Key Facts
Gilead Sciences, Inc. - Pipeline by Indication, 2016
Gilead Sciences, Inc. - Pipeline by Stage of Development, 2016
Gilead Sciences, Inc. - Monotherapy Products in Pipeline, 2016
Gilead Sciences, Inc. - Combination Treatment Modalities in Pipeline, 2016
Gilead Sciences, Inc. - Partnered Products in Pipeline, 2016
Gilead Sciences, Inc. - Partnered Products/ Combination Treatment Modalities, 2016
Gilead Sciences, Inc. - Out-Licensed Products in Pipeline, 2016
Gilead Sciences, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Gilead Sciences, Inc. - Pre-Registration, 2016
Gilead Sciences, Inc. - Phase III, 2016
Gilead Sciences, Inc. - Phase II, 2016
Gilead Sciences, Inc. - Phase I, 2016
Gilead Sciences, Inc. - Preclinical, 2016
Gilead Sciences, Inc. - Discovery, 2016
Gilead Sciences, Inc. - Pipeline by Target, 2016
Gilead Sciences, Inc. - Pipeline by Route of Administration, 2016
Gilead Sciences, Inc. - Pipeline by Molecule Type, 2016
Gilead Sciences, Inc. - Pipeline Products by Mechanism of Action, 2016
Gilead Sciences, Inc. - Recent Pipeline Updates, 2016
Gilead Sciences, Inc. - Dormant Developmental Projects,2016
Gilead Sciences, Inc. - Discontinued Pipeline Products, 2016
Gilead Sciences, Inc., Other Locations
Gilead Sciences, Inc., Subsidiaries
List of Figures
Gilead Sciences, Inc. - Pipeline by Top 10 Indication, 2016
Gilead Sciences, Inc. - Pipeline by Stage of Development, 2016
Gilead Sciences, Inc. - Monotherapy Products in Pipeline, 2016
Gilead Sciences, Inc. - Combination Treatment Modalities in Pipeline, 2016
Gilead Sciences, Inc. - Partnered Products in Pipeline, 2016
Gilead Sciences, Inc. - Out-Licensed Products in Pipeline, 2016
Gilead Sciences, Inc. - Pipeline by Top 10 Target, 2016
Gilead Sciences, Inc. - Pipeline by Route of Administration, 2016
Gilead Sciences, Inc. - Pipeline by Molecule Type, 2016
Gilead Sciences, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report